Antimicrobial Agents and Chemotherapy 2013-04-01

Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection.

Mairi Ziaka, Sophia L Markantonis, Marizoza Fousteri, Paris Zygoulis, Dimitris Panidis, Marios Karvouniaris, Demosthenes Makris, Epaminondas Zakynthinos

Index: Antimicrob. Agents Chemother. 57(4) , 1938-40, (2013)

Full Text: HTML

Abstract

Colistin pharmacokinetics were prospectively studied after intravenous administration of colistin methanesulphonate in critically ill patients without central nervous system infection (controls, n = 5) and in patients with external ventricular drain-associated ventriculitis after intravenous administration (EVDViv, n = 3) or combined intravenous/intraventricular administration (EVDVcomb, n = 4). Cerebrospinal fluid (CSF)/serum colistin concentration ratios were higher in EVDViv than in control patients (11% versus 7%, P ≤ 0.05) and in EVDVcomb compared to all other patients (P < 0.0001). CSF colistin concentrations above the MIC of 0.5 μg/ml were achieved only in EVDVcomb patients.


Related Compounds

Related Articles:

High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate.

2014-11-21

[J. Chromatogr. A. 1369 , 52-63, (2014)]

Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.

2015-01-01

[PLoS ONE 10 , e0142097, (2015)]

In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

2001-03-01

[Antimicrob. Agents Chemother. 45 , 781-785, (2001)]

Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler.

2012-09-01

[J. Pharm. Pharmacol. 64(9) , 1316-25, (2012)]

High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.

2012-06-01

[Clin. Infect. Dis. 54(12) , 1720-6, (2012)]

More Articles...